Summary
- Current Price
- As of today, CLRB price is $2.45, up +4.70% on
- Current Price All-Time High
- CLRB price is currently -100.00% below its historical high of $307,529,984.00 set on
- Market Cap
- CLRB current market cap is $20M, down -96.27% year-over-year
- PE Ratio
- CLRB PE ratio is unknown
- Revenue
- CLRB current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CLRB is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cellectar Biosciences, Inc. |
| Ticker | NASDAQ: CLRB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cellectar.com |
| Employees | 11 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.45 | ||
| Price, 1D Change | +4.70% | |
| $20M | ||
| - | ||
| - | ||
| 1.98 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$8.35 | ||
| EPS, 1Y Change | +80.06% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | NVLT | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$8.35 | ||
| EPS Estimate | N/A | -$2.05 |
| EPS Est. Change | N/A | +75.50% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $2.45 | ||
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +308.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.57 | -$41.89 | -2,572.42% | |
| -$9.27 | -$8.35 | +9.88% | |
| -$2.05 | N/A | +75.50% | |
| -$1.60 | N/A | +80.81% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $6.77M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -78.51% | ||
| -96.04% | ||
| -96.27% | ||
| -2.42% | ||
| 0.00% | ||
| 0.00% | ||
| +80.06% | ||
| +93.82% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $2.45 | ||
| $3.49 | ||
| $2.85 | ||
| $5.17 | ||
| $2.84 | ||
| -$0.18 | ||
| 1.98 | ||
| $0.23 | ||
| 35.19 | ||
| 73.63% | ||
| 92.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$8.35 | ||
| -$213.60K | ||
| - | ||
| -$22.98M | ||
| - | ||
| -$21.79M | ||
| - | ||
| -$22.77M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 2.96 | ||
| 2.96 | ||
| - | ||
| - | ||
| -27.15 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 6.96 | ||
| -0.57 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $8.02M | ||
| $13.20M | ||
| $14.98M | ||
| $14.04M | ||
| $5.06M | ||
| $4.75M | ||
| $409.60K | ||
| $100.20K | ||
| $1.44M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $21.79M | ||
| $22.77M | ||
| $213.60K | ||
| $0.00 | ||
| $213.60K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$23.12M | ||
| -$5,900.00 | ||
| $13.03M | ||
| $5,900.00 | ||
| -$23.12M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Oppenheimer | → | |
| Oppenheimer | → | |
| Roth MKM | → | |
| Oppenheimer | → | |
| Roth MKM | → | |
| HC Wainwright & Co. | ||
| Roth Capital | ||
| Oppenheimer |
Analyst sentiment
Institutional ownership
Screeners with CLRB
FAQ
What is the ticker symbol for Cellectar Biosciences, Inc.?
The ticker symbol for Cellectar Biosciences, Inc. is NASDAQ:CLRB
Does Cellectar Biosciences, Inc. pay dividends?
No, Cellectar Biosciences, Inc. does not pay dividends
What sector is Cellectar Biosciences, Inc. in?
Cellectar Biosciences, Inc. is in the Healthcare sector
What industry is Cellectar Biosciences, Inc. in?
Cellectar Biosciences, Inc. is in the Biotechnology industry
What country is Cellectar Biosciences, Inc. based in?
Cellectar Biosciences, Inc. is headquartered in United States
When did Cellectar Biosciences, Inc. go public?
Cellectar Biosciences, Inc. initial public offering (IPO) was on November 10, 2005
Is Cellectar Biosciences, Inc. in the S&P 500?
No, Cellectar Biosciences, Inc. is not included in the S&P 500 index
Is Cellectar Biosciences, Inc. in the NASDAQ 100?
No, Cellectar Biosciences, Inc. is not included in the NASDAQ 100 index
Is Cellectar Biosciences, Inc. in the Dow Jones?
No, Cellectar Biosciences, Inc. is not included in the Dow Jones index
When was Cellectar Biosciences, Inc. last earnings report?
Cellectar Biosciences, Inc.'s most recent earnings report was on May 14, 2026
When does Cellectar Biosciences, Inc. report earnings?
The next expected earnings date for Cellectar Biosciences, Inc. is August 13, 2026
Data Sources & References
- CLRB Official Website www.cellectar.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1279704/000110465926023167/0001104659-26-023167-index.htm
- CLRB Profile on Yahoo Finance finance.yahoo.com/quote/CLRB
- CLRB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clrb